Selected article for: "low titer and nucleic acid"

Author: Bradley, Daniel W.
Title: The agents of non-A, non-B viral hepatitis
  • Cord-id: jznp3n1n
  • Document date: 1985_4_30
  • ID: jznp3n1n
    Snippet: Abstract Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infected liver. The other agent is CHCl3-sensitive, induces the formation of characteristic hepatocyte cytoplasmic tubules, and interferes with concurrent HAV or HBV infection in experimentally in
    Document: Abstract Recent studies have provided physicochemical and electron microscopic evidence for the existence of two distinct agents of posttransfusion non-A, non-B (NANB) hepatitis. One of these agents is chloroform-resistant and is not associated with the formation of unique ultrastructural structures in infected liver. The other agent is CHCl3-sensitive, induces the formation of characteristic hepatocyte cytoplasmic tubules, and interferes with concurrent HAV or HBV infection in experimentally inoculated chimpanzees. The tubule-forming agent (TFA) has also been shown to pass through an 80 nm capillary pore membrane filter, suggesting that it is a small enveloped (or lipid-containing) virus. The TFA can also be recovered from low titer (⩽ 105 infectious doses/ml) chronic-phase chimpanzee plasma by use of a multi-step purification procedure that assumes the agent is a small enveloped RNA virus with an approximate buoyant density of 1.24 g/cm3 and a sedimentation coefficient of 200–280 S. The apparent lack of nucleic acid homology between the NANB-TFA and HBV further suggests that the NANB-TFA is either Togavirus-like or belongs to another or as yet undefined class of RNA or DNA virus.

    Search related documents:
    Co phrase search for related documents
    • acid homology and acute phase: 1
    • acid hybridization and acute disease: 1
    • acute disease and liver biopsy: 1, 2, 3, 4, 5, 6
    • acute disease and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver dysfunction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute disease and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • acute disease and low proportion: 1, 2, 3, 4, 5
    • acute phase and liver biopsy: 1, 2
    • acute phase and liver disease: 1, 2, 3, 4, 5, 6
    • acute phase and liver dysfunction: 1, 2, 3, 4
    • acute phase and liver enzyme: 1, 2
    • acute phase and low proportion: 1, 2
    • additional elevation and liver dysfunction: 1
    • additional elevation and liver enzyme: 1